FDA Approves Moxidectin for the Treatment of River Blindness

Article Link: FDA Approves Moxidectin for the Treatment of River Blindness

MELBOURNE, GENEVA, and NEW YORK – June 13, 2018 — Medicines Development for Global Health (MDGH) and the World Health Organisation Special Programme for Research and Training in Tropical Diseases (TDR) announced today that the United States (U.S.)…

Source: FDA New Drug Approvals